Pollack, Pia Chadwick, Kristina Smith, David Billger, Martin Hirshberg, Boaz Iqbal, Nayyar Boulton, David MOESM3 of Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptin Additional file 3. Saxagliptin and 5-hydroxy saxagliptin pharmacokinetic parameters for multiple ascending dose study in patients with T2DM. Diabetes mellitus;Pharmacology;Heart failure;Saxagliptin 2017-09-13
    https://springernature.figshare.com/articles/journal_contribution/MOESM3_of_Nonclinical_and_clinical_pharmacology_evidence_for_cardiovascular_safety_of_saxagliptin/5405854
10.6084/m9.figshare.c.3879460_D3.v1